Relation between clinical characteristics and the TCR-γ PCR results
Patient number . | Age at diagnosis, y . | Sex . | Stage . | Type of samples . | TCR-γ GR pattern . | Follow-up, mo . | Behavior . | Status at the last follow-up . |
---|---|---|---|---|---|---|---|---|
1 | 30 | M | IA | S | Stable GR | 181 | P | Alive with disease |
2 | 30 | F | IA | C | Common GR | 144 | P | Alive with disease |
3 | 68 | F | IA | C | Common GR | 96 | NP | Alive, CR |
4 | 44 | M | IA | C and S | No GR | 77 | NP | Alive with disease |
5 | 38 | M | IA | S | Stable GR | 70 | P | Alive with disease |
6 | 44 | F | IA | S | No GR | 66 | P | Alive, CR |
7 | 9 | F | IA | S | Stable GR | 64 | NP | Alive with disease |
8 | 39 | F | IA | C | Common GR | 43 | P | Alive with disease |
9 | 40 | M | IA | S | Stable GR | 39 | NP | Alive with disease |
10 | 66 | M | IA | C | Different GR | 38 | NP | Alive, CR |
11 | 59 | M | IB | C and S | Common and stable GR | 224 | P | DOD |
12 | 57 | M | IB | S | Stable GR | 133 | P | Alive with disease |
13 | 68 | F | IB | S | Stable GR | 63 | NP | Alive, CR |
14 | 60 | M | IIA | S | Stable GR | 159 | P | Alive with disease |
15 | 56 | M | IIA | S | Stable GR | 139 | P | Alive with disease |
16 | 62 | F | IIA | S | Stable GR | 66 | P | Alive with disease |
17 | 57 | M | IIA | LN | Different GR | 59 | NP | Died without disease |
18 | 60 | M | IIA | LN | Different GR | 36 | NP | Alive, CR |
19 | 50 | F | IIA | C | Common GR | 17 | P | Alive with disease |
20 | 37 | M | IIB | C and S | Common and stable GR | 387 | P | Alive with disease |
21 | 56 | M | IIB | C and S | Different and unstable GR | 240 | NP | Alive with disease |
22 | 17 | F | IIB | C and S | Common and stable GR | 234 | P | Alive with disease |
23 | 53 | M | IIB | C and S | Common and stable GR | 180 | P | DOD |
24 | 25 | F | IIB | C and S | Common and stable GR | 166 | P | Alive with disease |
25 | 61 | M | IIB | S and LN | Common and stable GR | 91 | P | Alive with disease |
26 | 61 | F | IIB | C and S | Different and stable GR | 87 | P | Alive with disease |
27 | 61 | M | IIB | C | Common GR | 46 | P | Alive with disease |
28 | 43 | F | IV | LN | Common GR | 100 | P | Alive, CR |
29 | 61 | F | IV | S | Unstable GR | 63 | P | Alive with disease |
30 | 73 | F | IV | C and LN | No GR | 41 | P | DOD |
31 | 73 | F | IV | LN | Common GR | 12 | P | DOD |
32 | 44 | M | IVA | C | Different GR | 146 | P | Alive with disease |
33 | 58 | F | IVA | S | Stable GR | 110 | P | Alive with disease |
34 | 66 | F | IVA | LN | Common GR | 93 | P | Alive with disease |
35 | 48 | M | IVA | LN | Common GR | 70 | P | DOD |
36 | 43 | F | IVA | S and LN | Common and stable GR | 52 | P | Alive with disease |
37 | 49 | M | IVA | LN | Common GR | 38 | P | Alive with disease |
38 | 25 | F | IVA | C | Common GR | 12 | P | DOD |
39 | 29 | F | IVB | LN | Common GR | 152 | P | Alive with disease |
Patient number . | Age at diagnosis, y . | Sex . | Stage . | Type of samples . | TCR-γ GR pattern . | Follow-up, mo . | Behavior . | Status at the last follow-up . |
---|---|---|---|---|---|---|---|---|
1 | 30 | M | IA | S | Stable GR | 181 | P | Alive with disease |
2 | 30 | F | IA | C | Common GR | 144 | P | Alive with disease |
3 | 68 | F | IA | C | Common GR | 96 | NP | Alive, CR |
4 | 44 | M | IA | C and S | No GR | 77 | NP | Alive with disease |
5 | 38 | M | IA | S | Stable GR | 70 | P | Alive with disease |
6 | 44 | F | IA | S | No GR | 66 | P | Alive, CR |
7 | 9 | F | IA | S | Stable GR | 64 | NP | Alive with disease |
8 | 39 | F | IA | C | Common GR | 43 | P | Alive with disease |
9 | 40 | M | IA | S | Stable GR | 39 | NP | Alive with disease |
10 | 66 | M | IA | C | Different GR | 38 | NP | Alive, CR |
11 | 59 | M | IB | C and S | Common and stable GR | 224 | P | DOD |
12 | 57 | M | IB | S | Stable GR | 133 | P | Alive with disease |
13 | 68 | F | IB | S | Stable GR | 63 | NP | Alive, CR |
14 | 60 | M | IIA | S | Stable GR | 159 | P | Alive with disease |
15 | 56 | M | IIA | S | Stable GR | 139 | P | Alive with disease |
16 | 62 | F | IIA | S | Stable GR | 66 | P | Alive with disease |
17 | 57 | M | IIA | LN | Different GR | 59 | NP | Died without disease |
18 | 60 | M | IIA | LN | Different GR | 36 | NP | Alive, CR |
19 | 50 | F | IIA | C | Common GR | 17 | P | Alive with disease |
20 | 37 | M | IIB | C and S | Common and stable GR | 387 | P | Alive with disease |
21 | 56 | M | IIB | C and S | Different and unstable GR | 240 | NP | Alive with disease |
22 | 17 | F | IIB | C and S | Common and stable GR | 234 | P | Alive with disease |
23 | 53 | M | IIB | C and S | Common and stable GR | 180 | P | DOD |
24 | 25 | F | IIB | C and S | Common and stable GR | 166 | P | Alive with disease |
25 | 61 | M | IIB | S and LN | Common and stable GR | 91 | P | Alive with disease |
26 | 61 | F | IIB | C and S | Different and stable GR | 87 | P | Alive with disease |
27 | 61 | M | IIB | C | Common GR | 46 | P | Alive with disease |
28 | 43 | F | IV | LN | Common GR | 100 | P | Alive, CR |
29 | 61 | F | IV | S | Unstable GR | 63 | P | Alive with disease |
30 | 73 | F | IV | C and LN | No GR | 41 | P | DOD |
31 | 73 | F | IV | LN | Common GR | 12 | P | DOD |
32 | 44 | M | IVA | C | Different GR | 146 | P | Alive with disease |
33 | 58 | F | IVA | S | Stable GR | 110 | P | Alive with disease |
34 | 66 | F | IVA | LN | Common GR | 93 | P | Alive with disease |
35 | 48 | M | IVA | LN | Common GR | 70 | P | DOD |
36 | 43 | F | IVA | S and LN | Common and stable GR | 52 | P | Alive with disease |
37 | 49 | M | IVA | LN | Common GR | 38 | P | Alive with disease |
38 | 25 | F | IVA | C | Common GR | 12 | P | DOD |
39 | 29 | F | IVB | LN | Common GR | 152 | P | Alive with disease |
S indicates sequential; C, concurrent; P, progressive; NP, nonprogressive; CR, complete remission; DOD, dead of disease; LN, lymph node.